SALT LAKE CITY – The Food and Drug Administration (FDA) is allowing more COVID-19 patients to receive plasma infusions from people who have recovered from the virus. And while doctors at Intermountain Healthcare are excited for the possibilities, they are also worried about shortages.
That’s why they are asking people who have kicked COVID-19 to donate plasma.
Intermountain Healthcare has been using plasma infusions for months now as part of a limited clinical trial with the Mayo Clinic in Minnesota.
During a news conference on Monday, Dr. Daanish Hoda said there are already shortages of plasma with COVID-19 antibodies.
“Now with the Emergency Use Authorization [from the FDA],” Hoda said, “we expect that those numbers will go up quite exponentially given that any patient at any hospital can get it without having to go through the extra work.”
Dr. Brandon Webb said Intermountain Healthcare has been able to treat 500 patients with plasma containing COVID-19 antibodies.
The higher the antibody count in the plasma, it seems, the better the patient does. However, he still urged recovered COVID-19 patients to donate.
“That actually highlights the importance of having as many people get out and donate as possible. Because the larger the pool, the larger the possible pool to learn from becomes,” Webb said.
Doctors also won’t know if someone has the needed amount of antibodies in their plasma until they donate and it’s tested.
The Red Cross and other local organizations have openings for people to donate their plasma.
COVID-19 coronavirusis transmitted from person to person. It is a virus that is similar to the common cold and the flu. So, to prevent it from spreading:
Utah’s Coronavirus Information
The Church of Jesus Christ of Latter-day Saints
Utah Coronavirus Information Line – 1-800-456-7707
Centers for Disease Control and Prevention